Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Previous studies suggest that brain-derived neurotrophic factor and its receptor TrkB are critically involved in the therapeutic actions of antidepressant drugs. We have previously shown that the antidepressants imipramine and fluoxetine produce a rapid autophosphorylation of TrkB in the rodent brain. In the present study, we have further examined the biochemical and functional characteristics of antidepressant-induced TrkB activation in vivo. We show that all the antidepressants examined, including inhibitors of monoamine transporters and metabolism, activate TrkB rapidly in the rodent anterior cingulate cortex and hippocampus. Furthermore, the results indicate that acute and long-term antidepressant treatments induce TrkB-mediated activation of phospholipase-Cgamma1 (PLCgamma1) and increase the phosphorylation of cAMP-related element binding protein, a major transcription factor mediating neuronal plasticity. In contrast, we have not observed any modulation of the phosphorylation of TrkB Shc binding site, phosphorylation of mitogen-activated protein kinase or AKT by antidepressants. We also show that in the forced swim test, the behavioral effects of specific serotonergic antidepressant citalopram, but not those of the specific noradrenergic antidepressant reboxetine, are crucially dependent on TrkB signaling. Finally, brain monoamines seem to be critical mediators of antidepressant-induced TrkB activation, as antidepressants reboxetine and citalopram do not produce TrkB ac…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research on the biological connections demonstrated that antidepressants activate the BDNF via tropomyosin receptor kinase B (TrkB) and a common transcription factor cAMP response element-binding protein (CREB; Koponen et al., 2005;Rantamaki et al., 2007).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Rantamaki et al., 2007
In the citing paper
“Antidepressant drugs require functional TrkB receptors to mediate antidepressant-like response in preclinical models (Rantamäki et al., 2007; Saarelainen et al., 2003).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“Rather intriguingly, chronic antidepressant treatment increases the phosphorylation of the TrkB receptor, thus increasing its activity, in the hippocampus and anterior cingulate cortex suggesting that BDNF-TrkB signaling in these brain regions may be critical in mediating antidepressant effects (Rantamäki et al., 2007).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“autophosphorylation of TrkB by antidepressants has also been reported by the group of Castren (Rantamaki et al. 2007; Saarelainen et al. 2003)”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2007
In the citing paper
“Other studies have found that antidepressants from a variety of chemical families (e.g., SSRIs, SNRIs, tricyclics, etc.) all increase activation of TrkB and its downstream effector CREB (140).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [140]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 4×
“Selected antidepressant doses have been routinely used in rodent models of behavioral despair (Porsolt et al, 1977; Wong et al, 2000; Drago et al, 2001; Weinstock et al, 2002; O’Leary et al, 2007).”
InfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“This FLX administration protocol has been previously shown to produce long-term alterations in neuroplasticity and animal behavior (Santarelli et al, 2003).”
InfluentialEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“Furthermore, val/met polymorphism in BDNF gene, which influences the activity-dependent BDNF release (Egan et al, 2003) has recently been associated with mood disorders in humans (Sklar et al, 2002; Lang et al, 2005).”
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 4×
“In addition, antidepressants block and accelerate the reversion of stress-induced downregulation in BDNF mRNA and protein, respectively (Nibuya et al, 1995; Xu et al, 2004).”
InfluentialBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Cited by
Items 101–200 of 348
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V. D., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · NORA - Norwegian Open Research Archives · Cited by 61
Henningsson, S., Borg, J., Lundberg, J., Bah, J., Lindström, M., Ryding, E., Jovanovic, H., Saijo, T., Inoue, M., Rosén, I., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.009 · Cited by 61
Kohtala, S., Theilmann, W., Rosenholm, M., Penna, L., Karabulut, G., Uusitalo, S., Järventausta, K., Yli-Hankala, A., Yalcin, I., Matsui, N., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1364-6 · Cited by 60
Self-citationMiltiadous, P., Stamatakis, A., Koutsoudaki, P. N., TINIAKOS, D. G., & Stylianopoulou, F. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.014 · Cited by 60
Karpova, N. N., Rantamäki, T., Lieto, A. D., Lindemann, L., Hoener, M. C., & Ċastrén, E. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9544-6 · Cited by 60
Self-citationBenmansour, S., Deltheil, T., Piotrowski, J. P., Nicolas, L., Repérant, C., Gardier, A. M., Frazer, A., & David, D. J. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.048 · Cited by 60
Pilar‐Cuéllar, F., Vidal, R., & Pazos, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01516.x · Cited by 59
Diniz, C. R. A. F., Casarotto, P. C., Resstel, L., & Joca, S. R. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.001 · Cited by 58
Mechanisms of antidepressant action: An integrated dopaminergic perspective
Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 58
Li, J., Zhou, Y., Liu, B.-B., Liu, Q. F., Geng, D., Lian-jin, W., & Yi, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/359682 · Cited by 58
BDNF receptor TrkB as the mediator of the antidepressant drug action
Casarotto, P., Umemori, J., & Castrén, E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1032224 · Cited by 50
Forebrain-specific ablation of phospholipase Cγ1 causes manic-like behavior
Yang, Y. R., Jung, J. H., Kim, S.-J., Hamada, K., Suzuki, A., Kim, H. J., Lee, J. H., Kwon, O.-B., Lee, Y. K., Kim, J., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.261 · Cited by 57
Ampuero, E., Luarte, A., Santibañez, M., Varas-Godoy, M., Toledo, J., Diaz-Veliz, G., Cavada, G., Rubio, F. J., & Wyneken, U. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv038 · Cited by 57
Lesnikova, A., Casarotto, P. C., Fred, S. M., Voipio, M., Winkel, F., Steinzeig, A., Antila, H., Umemori, J., Biojone, C., & Castrén, E. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2228-20.2020 · Cited by 56
“…but there are a number of other methods known to reactivate juvenile-like plasticity in the adult cortex (Bavelier et al., 2010), such as enriched environment (Nithianantharajah and Hannan, 2006; Sale et al., 2007, 2014) and cross-modal manipulation of sensory functions (Rodríguez et al., 2018).”
BackgroundChakrapani, S., Eskander, N., Santos, L. A. D. L., Omisore, B. A., & Mostafa, J. A. (2020) · Cureus · doi:10.7759/cureus.11396 · Cited by 57
Wang, Y., Wang, B., Lü, J., Shi, H., Gong, S., Wang, Y., Hamdy, R. C., Chua, B. H. L., Yang, L., & Xu, X. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14226 · Cited by 56
Tejeda, G. S., Esteban-Ortega, G. M., Antonio, E. S., Vidaurre, Ó. G., & Díaz‐Guerra, M. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809950 · Cited by 56
Reproductive Aging, Sex Steroids, and Mood Disorders
Harsh, V., Meltzer-Brody, S. E., Rubinow, D. R., & Schmidt, P. J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902891877 · Cited by 57
Di Lieto, A., Rantamäki, T., Vesa, L., Yanpallewar, S., Antila, H., Lindholm, J., Rios, M., Tessarollo, L., & Castrén, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032869 · Cited by 47
Self-citationGardier, A. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283243fcd · Cited by 54
Deltheil, T., Tanaka, K., Reperant, C., Hen, R., David, D. J., & Gardier, A. M. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000017 · Cited by 54
Gyárfás, T., Knuuttila, J. E. A., Lindholm, P., Rantamäki, T., & Ċastrén, E. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9458-3 · Cited by 55
Self-citationBarfield, E. T., & Gourley, S. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.015 · Cited by 53
Sallert, M., Rantamäki, T., Vesikansa, A., Anthoni, H., Harju, K., Yli-Kauhaluoma, J., Taira, T., Castren, E., & Lauri, S. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0560-09.2009 · Cited by 45
Self-citationFred, S. M., Laukkanen, L., Brunello, C. A., Vesa, L., Göös, H., Cardon, I., Moliner, R., Maritzen, T., Varjosalo, M., Casarotto, P. C., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008837 · Cited by 52
Yi, L., Li, J., Li, H.-C., Zhou, Y., Su, B.-F., Yang, K., Jiang, M., & Zhang, Y. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.016 · Cited by 52
Rantamäki, T., Kemppainen, S., Autio, H., Stavén, S., Koivisto, H., Kojima, M., Antila, H., Miettinen, P. O., Kärkkäinen, E., Karpova, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068722 · Cited by 51
Self-citationKohtala, S., Theilmann, W., Suomi, T., Wigren, H.-K., Porkka-Heiskanen, T., Elo, L. L., Rokka, A., & Rantamäki, T. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00002 · Cited by 51
Self-citationThe role of neurotrophic factors in novel, rapid psychiatric treatments
Kim, J., He, M. J., Widmann, A. K., & Lee, F. S. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01717-x · Cited by 51
Heinen, M., Hettich, M. M., Ryan, D. P., Schnell, S., Paesler, K., & Ehninger, D. (2012) · Neural Plasticity · doi:10.1155/2012/467251 · Cited by 46
A Review of Antidepressant Therapy in Primary Care: Current Practices and Future Directions
Kennedy, S. H. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01420 · Cited by 41
Antidepressant drug action--From rapid changes on network function to network rewiring
Rantamäki, T., & Yalcin, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.001 · Cited by 50
Self-citationNovel insights into the behavioral analysis of mice subjected to the forced-swim test
Chen, L., Faas, G. C., Ferando, I., & Módy, I. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.44 · Cited by 50
Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice
Zhang, S.-S., Tian, Y.-H., Jin, S.-J., Wang, W.-C., Zhao, J.-X., Si, X.-M., Zhang, L., Xu, H., & Jin, J.-Y. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05287-z · Cited by 49
Zhang, J., Liu, X., Sun, D., Fan, Y., Zhou, H., & Fu, B. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s58830 · Cited by 49
Rodríguez, P. M., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., Sameš, D., Scorza, C., & Carrera, I. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00152 · Cited by 48
BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Cubillos, S., Engmann, O., & Brancato, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214445 · Cited by 47
“Moreover, TrkB phosphorylation induced by either fluoxetine, citalopram, and reboxetine was also observed in serotonin transporter-deficient mice, suggesting that antidepressant drugs transactivate TrkB independently of BDNF and monoamine transporter blockade [18,19].”
BackgroundJu, L.-S., Yang, J.-J., Lei, L., Xia, J.-Y., Luo, D., Ji, M.-H., Martynyuk, A. E., & Yang, J.-J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00100 · Cited by 43
Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus
Autio, H., Mätlik, K., Rantamäki, T., Lindemann, L., Hoener, M. C., Chao, M., Arumäe, U., & Castrén, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.033 · Cited by 46
Self-citation7,8-Dihydroxyflavone reverses the depressive symptoms in mouse chronic mild stress
Zhang, M.-W., Zhang, S.-F., Li, Z.-H., & Han, F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.035 · Cited by 46
Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine
Su, H., Ma, C.-T., Yu, B., Chien, Y.-C., Tsai, C., Huang, W., Lin, C., Chuang, Y., Young, K.-C., Wang, J., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.06.015 · Cited by 46
Rantamäki, T., & Kohtala, S. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018697 · Cited by 45
“Rapid-acting antidepressants alleviate depression within hours, indicating that their mode of action is fundamentally different from conventional antidepressants, although the treatments trigger several shared molecular pathways (Rantamäki et al., 2007, 2011; Rantamäki, 2019).”
BackgroundSelf-citationRibeiro, D. E., Müller, H. K., Elfving, B., Eskelund, A., Joca, S. R., & Wegener, G. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119872173 · Cited by 45
TrkB neurotrophin receptor at the core of antidepressant effects, but how?
Rantamäki, T. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02985-6 · Cited by 45
Self-citationSensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice
Burke, T. F., Advani, T., Adachi, M., Monteggia, L. M., & Hensler, J. G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000466 · Cited by 42
Early induction of CREB activation and CREB-regulating signalling by antidepressants
Tardito, D., Musazzi, L., Tiraboschi, E., Mallei, A., Racagni, G., & Popoli, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000376 · Cited by 42
Neuronal cell adhesion genes and antidepressant response in three independent samples
Fabbri, C., Crisafulli, C., Gurwitz, D., Stingl, J., Calati, R., Albani, D., Forloni, G., Calabrò, M., Martines, R., Kasper, S. F., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.15 · Cited by 42
Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?
García-Bueno, B., Pérez-Nievas, B. G., & Leza, J. C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000970 · Cited by 41
Benmansour, S., Adeniji, O. S., Privratsky, A. A., & Frazer, A. (2015) · Neuroendocrinology · doi:10.1159/000437268 · Cited by 41
Targeting TrkB neurotrophin receptor to treat depression
Rantamäki, T., & Castrén, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.705 · Cited by 40
Self-citationWei, L., Kan, L.-Y., Zeng, H.-Y., Tang, Y.-Y., Huang, H., Xie, M., Zou, W., Wang, C., Zhang, P., & Tang, X. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8489-7 · Cited by 40
Arunrut, T., Alejandre, H., Chen, M., Cha, J., & Russo-Neustadt, A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.02.005 · Cited by 36
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance
Benmansour, S., Privratsky, A. A., Adeniji, O. S., & Frazer, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300165x · Cited by 41
Gardier, A. M., Guiard, B. P., Guilloux, J., Repérant, C., Coudoré, F., & David, D. J. P. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00640.x · Cited by 40
Emerging drugs for major depressive disorder
Kennedy, S. H., & Rizvi, S. J. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903107751 · Cited by 39
Miskolczi, C., Halász, J., & Mikics, É. (2018) · Pediatric Research · doi:10.1038/s41390-018-0205-7 · Cited by 39
Dedoni, S., Olianas, M. C., Ingianni, A., & Onali, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07766.x · Cited by 33
Shah, A., Carreno, F. R., & Frazer, A. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.83 · Cited by 35
Cray, J., Weinberg, S. M., Parsons, T. E., Howie, R. N., Elsalanty, M. E., & Yu, J. C.-K. (2014) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23323 · Cited by 38
Shah, A. P., Carreno, F. R., Wu, H., Chung, Y. A., & Frazer, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.024 · Cited by 38
Koskimäki, J., Matsui, N., Umemori, J., Rantamäki, T., & Ċastrén, E. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0110-5 · Cited by 37
Self-citationHerbert, J., Ban, M., Brown, G. W., Harris, T. O., Ogilvie, A., Uher, R., & Craig, T. K. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107037 · Cited by 24
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 34
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 33
Liu, H., Wei, H., Wu, L., Liu, S., Tang, Y., Zou, W., Wang, C., Zhang, P., & Tang, X. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13201 · Cited by 32
Neurotrophic basis to the pathogenesis of depression and phytotherapy
Wang, H., Yang, Y., Pei, G., Wang, Z., & Chen, N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1182666 · Cited by 32
Sales, A. J., Maciel, I. D. S., Suavinha, A. C. D. R., & Joca, S. R. L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02145-4 · Cited by 31
Antidepressant effect of Jujuboside A on corticosterone-induced depression in mice
Li, H., Li, J., Zhang, T., Xie, X., & Gong, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.076 · Cited by 31
(R)-fluoxetine enhances cognitive flexibility and hippocampal cell proliferation in mice
Marwari, S., & Dawe, G. S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754733 · Cited by 31
- Brain-Derived Neurotrophic Factor in Suicide Pathophysiology
(2012) · The Neurobiological Basis of Suicide · doi:10.1201/b12215-14 · Cited by 30
Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Albukhaty, S., Albuhadily, A. K., Al-Gareeb, A. I., Klionsky, D. J., & Abomughaid, M. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70167 · Cited by 30
Carreno, F. R., & Frazer, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000977 · Cited by 29
Kohtala, S., Theilmann, W., Rosenholm, M., Müller, H. K., Kiuru, P. S., Wegener, G., Yli‐Kauhaluoma, J. T., & Rantamäki, T. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107684 · Cited by 29
Self-citationProteomic and metabolomic characterization of amygdala in chronic social defeat stress rats
Fan, L., Yang, L., Li, X., Teng, T., Xiang, Y., Liu, X., Jiang, Y., Zhu, Y., Zhou, X., & Xie, P. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113407 · Cited by 29
Antidepressants for neuroprotection in Huntington's disease: A review
Jamwal, S., & Kumar, P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.033 · Cited by 30
Serotonin Hyperinnervation Abolishes Seizure Susceptibility inOtx2Conditional Mutant Mice
Tripathi, P. P., Giovannantonio, L. G. D., Viegi, A., Wurst, W., Simeone, A., & Bozzi, Y. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2208-08.2008 · Cited by 29
Sakata, K., Mastin, J. R., Duke, S. M., Vail, M. G., Overacre-Delgoffe, A. E., Dong, B. E., & Jha, S. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12148 · Cited by 29
Stanquini, L. A., Biojone, C., Guimarães, F. S., & Joca, S. R. L. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.28 · Cited by 28
Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Bajaj, S., & Mahesh, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09170-1 · Cited by 28
Cassimjee, N., Fouche, J.-P., Burnett, M., Löchner, C., Warwick, J., Dupont, P. J., Stein, D. J., Cloete, K. J., & Carey, P. D. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9218-6 · Cited by 28
Epigenetic Mechanisms of Rapid-Acting Antidepressants
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03055-y · Cited by 27
“TRKB signaling-mediated epigenetic effects Like classical antidepressants [181], a mechanism that might mediate the epigenetic effects of RAADs is the activation of endogenous BDNF signaling through direct binding to and activation of the TRKB receptor [182 – 185].”
BackgroundAMPA Receptors: A Target for Novel Antidepressants?
Skolnick, P. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.011 · Cited by 27
Popova, D., Ágústsdóttir, A., Lindholm, J., Mazulis, U., Akamine, Y., Castrén, E., & Karpova, N. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.04.002 · Cited by 26
“This protocol of chronic fluoxetine administration to adult mice was reported to results in clinically relevant plasma fluoxetine levels (Dulawa et al., 2004; Rantamaki et al., 2007) and to effectively produce behavioral alterations in depression- and anxiety-like behaviors (Karpova et al.”
Hara, H., Suzuki, A., Kunugi, A., Tajima, Y., Yamada, R. X., & Kimura, H. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173289 · Cited by 26
The multifaceted effects of fluoxetine treatment on cognitive functions
Ampuero, E., Luarte, A., Flores, F. S., Soto, A. I., Pino, C. H., Silva, V., Erlandsen, M., Concha, T., & Wyneken, Ú. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412420 · Cited by 26
Hennings, J. M., Kohli, M. A., Czamara, D., Giese, M., Eckert, A., Wolf, C., Heck, A., Domschke, K., Arolt, V., Baune, B. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064947 · Cited by 26
Could a blood test for PTSD and depression be on the horizon?
Aspesi, D., & Pinna, G. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1544894 · Cited by 27
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology.
Rusciano, I., Marvi, M. V., Obeng, E. O., Mongiorgi, S., Ramazzotti, G., Follo, M., Zoli, M., Morandi, L., Asioli, S., Fabbri, V. P., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100771 · Cited by 19
BDNF, A Focus to Major Depression
de Nazareth, A. M. (2021) · Trends journal of sciences research · doi:10.31586/ojp.2021.161 · Cited by 25
Nejati, S., Khakpai, F., & Zarrindast, M. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146701 · Cited by 25
Pharmacological exposures may precipitate craniosynostosis through targeted stem cell depletion
Durham, E. L., Howie, R. N., Larson, N., LaRue, A. C., & Cray, J. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101528 · Cited by 25
Spulber, S. D., Conti, M., DuPont, C. M., Raciti, M., Bose, R. K., Onishchenko, N. R., & Ceccatelli, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.94 · Cited by 26
Neurotrophin Genes and Antidepressant-Worsening Suicidal Ideation: A Prospective Case-Control Study
Voegeli, G., Ramoz, N., Shekhtman, T., Courtet, P., Gorwood, P. A. P. M., & Kelsoe, J. R. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw059 · Cited by 24
Stevanović, I. D., Mancic, B., Ilic, T. V., Milosavljević, P., Lavrnja, I. C., Stojanović, I. R., & Ninković, M. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.86294 · Cited by 24
Bobo, W. V., & Shelton, R. C. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.44 · Cited by 24
Li, S., Shao, H., Sun, T., Guo, X., Zhang, X., Zeng, Q., Fang, S., Liu, X., Jia, Q., Liu, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366683 · Cited by 23
Zhang, M., Li, R., Wang, Y., & Huang, Z. (2017) · Neural Plasticity · doi:10.1155/2017/5870735 · Cited by 23
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21
“However, phosphorylation at Tyr816 residue in the mice hippocampus was detected 1 h after acute administration of fluoxetine, riboxetine, citalopram, imipramine; a similar effect on the phosphorylation of Tyr816 was also established upon long-term administration (21 days) of fluoxetine [19].”
BackgroundResultRibeiro, D. E., Casarotto, P. C., Staquini, L., Pinto e Silva, M. A., Biojone, C., Wegener, G., & Joca, S. (2019) · PeerJ · doi:10.7717/peerj.7834 · Cited by 21
Demin, K. A., Krotova, N. A., Ilyin, N. P., Galstyan, D. S., Kolesnikova, T. O., Strekalova, T. V., de Abreu, M. S., Petersen, E. V., Zabegalov, K. N., & Kalueff, A. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-22688-x · Cited by 21
Metadata
- Authors
- Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- GlaxoSmithKline (Italy) (IT)
- NYU Langone Health (US)
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-21
- Volume
- 32
- Issue
- 10
- Pages
- 2152-2162
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2064468814
- Cited by
- 305
- References
- 75
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 18 · 2023: 17 · 2022: 15 · 2021: 15 · 2020: 18 · 2019: 18 · 2018: 14 · 2017: 20 · 2016: 13 · 2015: 16 · 2014: 15 · 2013: 18 · 2012: 20
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Iris (University of Trento) (submittedVersion)
- Funders
- GlaxoSmithKline
- Academy of Finland
- Suomen Kulttuurirahasto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, TrkB receptor, brain-derived neurotrophic factor, phospholipase C-gamma1, CREB, monoamine transporters, citalopram, reboxetine, serotonin depletion, norepinephrine depletion, anterior cingulate cortex, hippocampus, forced swim test, monoamine signaling
- MeSH terms
- Reboxetine, Animals, Antidepressive Agents, Binding Sites, Brain, Brain Chemistry, Depressive Disorder, Gyrus Cinguli, Hippocampus, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Morpholines, Phosphorylation, Citalopram, Signal Transduction, Up-Regulation, Cyclic AMP Response Element-Binding Protein, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice, Phospholipase C gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.